133 related articles for article (PubMed ID: 7726322)
1. Double-blind, controlled trial of inositol treatment of depression.
Levine J; Barak Y; Gonzalves M; Szor H; Elizur A; Kofman O; Belmaker RH
Am J Psychiatry; 1995 May; 152(5):792-4. PubMed ID: 7726322
[TBL] [Abstract][Full Text] [Related]
2. Follow-up and relapse analysis of an inositol study of depression.
Levine J; Barak Y; Kofman O; Belmaker RH
Isr J Psychiatry Relat Sci; 1995; 32(1):14-21. PubMed ID: 7622343
[TBL] [Abstract][Full Text] [Related]
3. Controlled trials of inositol in psychiatry.
Levine J
Eur Neuropsychopharmacol; 1997 May; 7(2):147-55. PubMed ID: 9169302
[TBL] [Abstract][Full Text] [Related]
4. Methylphenidate in mild depression: a double-blind controlled trial.
Mattes JA
J Clin Psychiatry; 1985 Dec; 46(12):525-7. PubMed ID: 3905773
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.
Calabrese JR; Keck PE; Macfadden W; Minkwitz M; Ketter TA; Weisler RH; Cutler AJ; McCoy R; Wilson E; Mullen J
Am J Psychiatry; 2005 Jul; 162(7):1351-60. PubMed ID: 15994719
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.
Lecrubier Y; Clerc G; Didi R; Kieser M
Am J Psychiatry; 2002 Aug; 159(8):1361-6. PubMed ID: 12153829
[TBL] [Abstract][Full Text] [Related]
7. Inositol treatment of obsessive-compulsive disorder.
Fux M; Levine J; Aviv A; Belmaker RH
Am J Psychiatry; 1996 Sep; 153(9):1219-21. PubMed ID: 8780431
[TBL] [Abstract][Full Text] [Related]
8. Inositol augmentation of lithium or valproate for bipolar depression.
Eden Evins A; Demopulos C; Yovel I; Culhane M; Ogutha J; Grandin LD; Nierenberg AA; Sachs GS
Bipolar Disord; 2006 Apr; 8(2):168-74. PubMed ID: 16542187
[TBL] [Abstract][Full Text] [Related]
9. CSF inositol does not predict antidepressant response to inositol. Short communication.
Levine J; Kurtzman L; Rapoport A; Zimmerman J; Bersudsky Y; Shapiro J; Belmaker RH; Agam G
J Neural Transm (Vienna); 1996; 103(12):1457-62. PubMed ID: 9029413
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).
McElroy SL; Weisler RH; Chang W; Olausson B; Paulsson B; Brecher M; Agambaram V; Merideth C; Nordenhem A; Young AH;
J Clin Psychiatry; 2010 Feb; 71(2):163-74. PubMed ID: 20122366
[TBL] [Abstract][Full Text] [Related]
11. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.
Nierenberg AA; Ostacher MJ; Calabrese JR; Ketter TA; Marangell LB; Miklowitz DJ; Miyahara S; Bauer MS; Thase ME; Wisniewski SR; Sachs GS
Am J Psychiatry; 2006 Feb; 163(2):210-6. PubMed ID: 16449473
[TBL] [Abstract][Full Text] [Related]
12. Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder.
Benjamin J; Levine J; Fux M; Aviv A; Levy D; Belmaker RH
Am J Psychiatry; 1995 Jul; 152(7):1084-6. PubMed ID: 7793450
[TBL] [Abstract][Full Text] [Related]
13. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression.
Schmidt PJ; Daly RC; Bloch M; Smith MJ; Danaceau MA; St Clair LS; Murphy JH; Haq N; Rubinow DR
Arch Gen Psychiatry; 2005 Feb; 62(2):154-62. PubMed ID: 15699292
[TBL] [Abstract][Full Text] [Related]
14. Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep.
Endicott J; Paulsson B; Gustafsson U; Schiöler H; Hassan M
J Affect Disord; 2008 Dec; 111(2-3):306-19. PubMed ID: 18774180
[TBL] [Abstract][Full Text] [Related]
15. Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients: a double-blind, placebo-controlled study.
DeBattista C; Posener JA; Kalehzan BM; Schatzberg AF
Am J Psychiatry; 2000 Aug; 157(8):1334-7. PubMed ID: 10910802
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients.
Mendels J; Reimherr F; Marcus RN; Roberts DL; Francis RJ; Anton SF
J Clin Psychiatry; 1995; 56 Suppl 6():30-6. PubMed ID: 7649971
[TBL] [Abstract][Full Text] [Related]
17. Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial.
Hirschfeld RM; Keck PE; Kramer M; Karcher K; Canuso C; Eerdekens M; Grossman F
Am J Psychiatry; 2004 Jun; 161(6):1057-65. PubMed ID: 15169694
[TBL] [Abstract][Full Text] [Related]
18. Response to treatment with antidepressants of patients with severe or moderate nonpsychotic depression and of patients with psychotic depression.
Kocsis JH; Croughan JL; Katz MM; Butler TP; Secunda S; Bowden CL; Davis JM
Am J Psychiatry; 1990 May; 147(5):621-4. PubMed ID: 2183635
[TBL] [Abstract][Full Text] [Related]
19. Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study.
Vieta E; Calabrese JR; Goikolea JM; Raines S; Macfadden W;
Bipolar Disord; 2007 Jun; 9(4):413-25. PubMed ID: 17547587
[TBL] [Abstract][Full Text] [Related]
20. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression.
Marangell LB; Martinez JM; Zboyan HA; Kertz B; Kim HF; Puryear LJ
Am J Psychiatry; 2003 May; 160(5):996-8. PubMed ID: 12727707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
